Barclays Maintains Overweight on HCA Healthcare, Raises Price Target to $367

HCA Holdings, Inc. +0.13%

HCA Holdings, Inc.

HCA

322.16

+0.13%

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE: HCA) with a Overweight and raises the price target from $356 to $367.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via